Matt Zuga, CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc. (ABOS), sold 29,810 shares at $1.96 ($59K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Seasonal sale ($59k) by CFO & Chief Business Officer — this insider has traded ABOS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.96 | 4,000 | $8K | 13.3% |
| 2 | $1.96 | 4,000 | $8K | 13.3% |
| 3 | $1.97 | 5,100 | $10K | 17.0% |
| 4 | $1.97 | 5,100 | $10K | 17.1% |
| 5 | $1.99 | 1,700 | $3K | 5.7% |
| 6 | $1.99 | 1,700 |
| $3K |
| 5.7% |
| 7 | $2.00 | 4,105 | $8K | 13.9% |
| 8 | $2.00 | 4,105 | $8K | 13.9% |
| Total | $1.98 avg | 29,810 | $59K | 100% |
| Filing → |
| ABOS | SELL | 2025-01-23 | $57K | — | Filing → |
| ABOS | SELL | 2025-01-07 | $24K | — | Filing → |
| ABOS | SELL | 2024-01-19 | $16K | — | Filing → |